NCT02134977View on ClinicalTrials.gov

"Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey: QOL Survey in Premenopausal Breast Cancer Patients"

CompletedOBSERVATIONAL
Enrollment

2,816

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Breast Cancer
Interventions
DRUG

Leuprorelin Acetate

Leuprorelin Acetate SR 11.25 mg Injection Kit

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY